Sangamo BioSciences reported U$13 million in Sales Revenues for its first quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acceleron Pharma U$ 39M 35M
Alnylam Pharmaceuticals U$ 103M 4M
Amgen U$ 6206M 45M
Bayer € 10054M 2791M
Biocryst Pharmaceuticals U$ 2M 2M
Biogen U$ 3376.1M 305.5M
Biomarin Pharmaceutical U$ 429.485M 72.584M
Bluebird Bio U$ 198.89M 177.027M
Gilead Sciences U$ 5143M 405M
GlaxoSmithKline 7624M 1466M
Intercept Pharmaceuticals U$ 77.249M 4.597M
Johnson & Johnson 21082M 2746M
Merk U$ 10872M 1185M
Pfizer U$ 11801M 227M
Sarepta Therapeutics U$ 137M 24M
Ultragenyx Pharmaceutical U$ 61.709M 25.4M
Vertex Pharmaceuticals U$ 1524.485M 9.378M